Neudle.com: antiviral agents

Differential
(Click to cross reference)

abscess, intracerebral

abscess, intracerebral, multiple

abscess, intracerebral, tuberculous

abulia

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome defining illness

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome myelopathy

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

activities of daily living

acute disseminated encephalomyelitis

acute necrotizing encephalitis

acyclovir

adalimumab

addiction, heroin-neurologic complications with

adenine arabinoside

advances in neurology

adverse drug reaction

altered states of consciousness

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis-like syndrome

aneurysm, intracranial

angiitis

angiography, cerebral

ankle clonous

anorexia

anosmia

anterior tibial muscle weakness

anti DNA agent

antiarrhythmic drugs

antibiotics

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anticonvulsants, untoward effects of

arthropathy, neuropathic

aspartate aminotransferase

attention deficit disorder with hyperactivity

bacterial infection, CNS

basal cell carcinoma

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

basilar artery stenosis

behavior, combative

behavioral disorder

BENEFIT study

beta adrenergic blocker

blacks

bladder dysfunction

blood brain barrier

bone marrow transplantation

brain biopsy, indication

brain biopsy, stereotaxic

calcification, intracranial

CAT scan, angiography

CAT scan, chest

CAT scan, contrast enhanced

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, subepend.

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, ring sign

cataracts, congenital

cauda equina

cauda equina, enhancement

cauda equina, lesion of

CD19-directed chimeric antigen receptor T-cell therapy

CD4 counts

CD8 encephalitis

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, red cells in

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, clinical diagnosis

cerebrovascular accident, delayed onset

cerebrovascular accident, differential diagnosis of

cerebrovascular accident, mimics

Charcot joint

chemotherapy, CNS treatment and complications with

choroid plexus, enhancement

chromosome 4

chronic fatigue syndrome

Churg-Strauss syndrome

ciprofloxacin

Clinical Pathologic Conference(C.P.C.)

concentration, impaired

confusion

confusional state, acute

congenital infection, CNS

congenital infection, viral

conjunctival injection

contrast agents, neurotoxicity of

controversies in neurology

cop 1

coronavirus

corpus callosum, lesion of

cranial nerve enhancement

cranial nerve palsies

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

cryptococcal meningitis

cryptococcoma, cerebral

cytokine release syndrome

cytokines

cytomegalic inclusion disease

cytomegalovirus infection

cytomegalovirus infection, congenital

cytosine arabinoside

daclizumab

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

dementia, rapidly progressive

dementia, subcortical

dementia, treatment of

demyelinating disease

deprenyl

depression

depression, psychotic

developmental disability

developmental evaluation

developmental retardation

differential diagnosis

difficulty climbing stairs

difficulty going down stairs

diffuse infiltrative lymphocytosis syndrome

dilantin

disability rating scale, neurological

disability, neurological

disorientation

distal muscle weakness

dizziness

drowsiness

drug abuse

drug induced neurologic disorders

drug induced neurologic disorders in children

electroencephalogram, abnormalities of

electroencephalogram, diffuse slowing

electroencephalogram, periodic complexes

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, clinical picture and treatment of

encephalitis, diagnosis of

encephalitis, etiology

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, Rasmussen's

encephalitis, recurrent

encephalitis, unknown etiology

encephalitis, viral

encephalitis, viral-causes of

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, acute

ependymitis

epidemiology of neurology

evidence-based research

executive dysfunction

facial nerve palsy, causes of

facial nerve palsy, prognosis of

facial nerve palsy, surgical treatment

facial nerve palsy, treatment of

facial nerve, lesion of

finger nose finger test

frontal lobe, pathologic signs of

fundus, abnormality of

fungal infection

fungal infection, CNS

gadolinium

gait disorder

gait, apraxic

gammaglobulin therapy, intravenous

genetic neurologic disorders

glioblastoma multiforme(astrocytoma Gr.III)

glucose tolerance test, abnormal

gram positive rod

granule cell

grasp reflex

Guillain Barre syndrome

H1N1 influenza

hallucination

hallucination, auditory

hallucination, olfactory

hallucination, visual

headache

headache, drug induced

headache, frontal

headache, progressive

headache, severe

hearing loss

hematuria, microscopic

heralding manifestation

herniation syndromes, intracranial

herpes encephalitis

herpes labialis

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, diagnosis of

herpes simplex encephalitis, differential diagnosis of

herpes simplex encephalitis, infancy and childhood

herpes simplex encephalitis, prognosis of

herpes simplex encephalitis, recurrent

herpes simplex encephalitis, treatment of

herpes simplex myelitis

herpes simplex virus

herpes simplex virus infection, immunosuppressed patient

herpes simplex virus infection, newborn

herpes simplex virus, human nervous system and

herpes simplex virus, localization of

herpes simplex virus, malignancy with

herpes simplex virus, pathogenesis of

herpes simplex virus, pathology of

herpes simplex, neurocutaneous lesions in

herpes virus

herpes virus infection

herpes zoster

herpes zoster, disseminated

herpes zoster, myelitis

herpes zoster, ophthalmicus

highly active antiretroviral therapy

hip flexor weakness

hippocampal atrophy

hippocampus

hippocampus, hyperintense

HIV CSF viral escape syndrome

HIV-associated neurocognitive disorder

human immunodeficiency virus type 1

human immunodeficiency virus type 1, acute infection

human immunodeficiency virus type 1, asymptomatic

human immunodeficiency virus type 1, false positive

human immunodeficiency virus type 1, infants and children

human immunodeficiency virus type 1, pathogenesis

human immunodeficiency virus type 1, prophylaxis

human immunodeficiency virus type 1, testing

human immunodeficiency virus type 2

human papilloma virus

human T-lymphotropic virus type I(HTLV-I)

hydrocephalus

hydrocephalus, exvacuo

iatrogenic neurologic disorders

ibuprofen

idiopathic thrombocytopenic purpura

imbalance

imbalance, postural

immune effector cell-associated neurotoxicity syndrome

immune reconstitution inflammatory syndrome

immune reconstitution inflammatory syndrome, paradoxical

immune reconstitution inflammatory syndrome, unmasked

immune-related adverse events

immunocompetent

immunodeficiency

immunofluorescence

immunofluorescent exam of CSF cells

immunohistochemistry

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

impulsivity

inappropriate antidiuretic(A.D.H.)hormone

inattention

inclusion bodies

inclusion bodies, eosinophilic intranuclear

inclusion bodies, intranuclear

indinavir

infection

infectious mononucleosis

infectious mononucleosis, neurologic findings with

infliximab

influenza

influenza A virus

influenza immunization

inosiplex

insular cortex

intellectual deficit

intellectual deterioration

interferon

interferon alpha

interferon antibodies

interferon, intrathecal

interferon, intraventricular

intestinal obstruction

intracranial pressure, increased

intrathecal chemotherapy

intrauterine

intrauterine infection

intrauterine infection, viral

intrauterine infection, viral of CNS

intraventricular chemotherapy

iododeoxyuridine

Jakob-Creutzfeldt disease

leg weakness, bilateral

leg weakness, unilateral

lethargy

leukemia

leukemia, neurologic findings assoc.with

level of consciousness, decreased

liver function enzymes

lumbar puncture

lumbar puncture, complications of

lumbar puncture, indications for

lumbosacral radiculopathy

lymphadenopathy

lymphoma

lymphoma involving CNS

lymphoma, plasmablastic

lymphoma, primary of CNS

lymphoma, systemic

lymphopenia

lysosomal storage disease

malformation, CNS, congenital

medication withdrawal

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, carcinomatous

meningitis, leukemic

meningitis, Mollaret's

meningitis, recurrent

meningitis, spinal fluid smear and culture-negative

meningitis, treatment of

meningoencephalitis

menses

menses, irregular

mental status, abnormal

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery territory infarction

middle cerebral artery, stenosis of

migraine

migraine, seizures in

mimics

misdiagnosis

mitochondrial disease

molecular genetics

monoamines

monoamines, brain

monoclonal antibodies

mononeuropathy multiplex

mortality

motor neuron disease

movement disorder

movement disorder, extrapyramidal

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, subependymal

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, high signal intensity of basal ganglia

MRI, hypointense signal foci on

MRI, indications for

MRI, magnetization transfer sequence

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, sulcal hyperintensity

MRI, volumetry

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, worsening

muscle atrophy, progressive

muscle biopsy

muscle pain

muscle strength, testing

muscle tenderness

muscle wasting, diffuse

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

mycobacterium avium-intracellulare

mycoplasma pneumoniae

myelitis

myelitis, transverse

myelitis, transverse, recurrent

myelopathy

myelopathy, ascending

myopathy, drug-induced

myopathy, mitochondrial

myopathy, necrotizing

nemaline rod myopathy

nemaline rod myopathy, adult onset

neonatal infection, viral

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

nerve biopsy

nerve block

nerve conduction studies

nerve root enhancement

nerve root hypertrophy

neuralgia

neurofibrillary degeneration

neuroleptic

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic history

neurologic signs

neurologic symptoms

neuromuscular blockade

neuronopathy

neuropathology

neuropathology, brain

neuropathy

neuropathy, acute

neuropathy, cryoglobulinemic

neuropathy, demyelinating

neuropathy, iatrogenic

neuropathy, medication induced

neuropathy, painful

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, nonsystemic

neurosyphilis

neurotoxic

neurotoxin

neutralizing antibodies

neutropenia

nicotine

nocardiosis

nonsteroidal anti-inflammatory drug

number needed to treat

nystagmus

old age, neurology of

Ommaya reservoir

opportunistic infection

opportunistic infection, CNS

optic atrophy

optic neuritis

optic neuropathy

optic neuropathy, ischemic

optic neuropathy, ischemic, posterior

organ transplantation

pain, management of chronic

paresthesias, circumoral

paresthesias, facial

paresthesias, feet

Parkinson disease

Parkinson disease, young onset

Parkinsonism syndrome

parotid gland swelling

patient information and support

penicillamine

peripheral blood stem cell transplantation

peripheral pulse, absent

pleocytosis of cerebrospinal fluid

pleurisy

pneumocystis carinii

polyinosinic cytidic acid(poly IC)

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

polyradiculoneuropathy

pons, lesion of

positive sharp waves

post herpetic neuralgia

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

preexposure prophylaxis

pregnancy, neurologic complications in

preherpetic neuralgia

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive multifocal leukoencephalopathy, etiology

progressive neurologic disorder

protease inhibitor, HIV-1

proximal muscle atrophy

pseudocyst

psoriatic arthritis

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychosis

pulmonary infiltrates

pyramidal tract dysfunction

pyramidal tract dysfunction, unilateral

radiation therapy, CNS treatment and complications with

radiation therapy, total body

remote effect of cancer on the nervous system

renal failure

renal failure, acute

renal stones

renal transplantation

research

respiratory failure

respiratory tract infection

reversible cerebral vasoconstrictive syndromes

salivary gland enlargement

saquinavir

sarcoidosis

screening

sedimentation rate, elevated

seizure

seizure, drug-induced

seizure, focal

seizure, intractable

seizure, neonatal

seizure, psychomotor-temporal lobe

seizure, treatment of

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory ganglia

seroconversion

serologic testing

serologic testing of cerebrospinal fluid

seronegative

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

sexually transmitted disease

sicca syndrome

single photon emission computed tomography

single photon emission computed tomography, thallium

skin, discoloration

skin, lesions in neurologic disorders

slow virus infection of CNS

small for dates infant, problems in

snout reflex

soap-bubble appearance

spinal cord, lesion of

splenectomy

statin therapy

status epilepticus

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

striatal encephalitis

striatum, lesion of, bilateral

stroke center

stuporous

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

subdural hematoma

subdural hematoma, bilateral

subdural hematoma, posterior fossa

subtemporal decompression

sumatriptan

symmetric brain lesions

sympathetic block

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

temporal artery, biopsy

temporal lobe, lesion

temporal lobe, lesion, bilateral

temporal lobectomy

term infant

tetrahydroaminoacridine

transcutaneous electrical nerve stimulation

transient ischemic attack

transplacental virus infections

travel history

treatment delay

treatment of neurologic disorder

treatment, empirical

tremor

tremor, intention

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, surgical treatment of

tumor necrosis factor inhibitor

ultrasonography, head

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

ventricular enlargement

vincristine neurotoxicity

viral escape

viral infection

viral infection, CNS

viral infection, CNS, treatment of

viral isolation

viral load

Virchow-Robin spaces, dilated

visual impairment

visual loss

visual loss, sudden-unilateral

walking, delayed

walking, difficulty with

weakness

weakness, focal

weakness, generalized

weakness, progressive

web sites

weight loss

Wernicke's encephalopathy

West Nile fever

Western immunoblot test

white matter disease

white matter, dirty-appearing

wide based gait

word-finding difficulty

Showing articles 2050 to 2100 of 3506 << Previous Next >>

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999

Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999

Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999

Migraine in Pregnancy
Neurol 53:S26-S28, Aube,M., 1999

Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999

Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999

Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999

Adult-Onset "Infant" Botulism:An Unusual Cause of Weakness in the Intensive Care Unit
Neurol 53:891, Li,L.Y.J.,et al, 1999

Edema Associated with Calcified Lesions in Neurocysticercosis
Neurol 53:777-781, Nash,T.E.&Patronas,N.J., 1999

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999

Ischemic Core and Penumbra in Human Stroke
Stroke 30:93-99, Kaufmann,A.M.,et al, 1999

Intra-Arterial rtPA Treatment of Stroke Assessed by Diffusion- and Perfusion-Weighted MRI
Stroke 30:678-680, Lansberg,M.G.,et al, 1999

Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
Stroke 30:287-292, Krieger,D.W.,et al, 1999

Risk Factor Modification in Stroke Prevention,The Experience of a Stroke Clinic
Stroke 30:16-20, Joseph,L.N.,et al, 1999

The Effects of Mannitol on Cerebral Edema after Large Hemispheric Cerebral Infarct
Neurol 52:583-587, Manno,E.M.,et al, 1999

Herpes Varicella Zoster Encephalitis in Immunocompromised Patients
Neurol 52:193-195, Weaver,S.,et al, 1999

Cerebral Tumor-Like American Trypanosomiasis in Acquired Immunodeficiency Syndrome
Ann Neurol 45:403-406, Pagano,M.A.,et al, 1999

Progressive Multifocal Leukoencephalopathy in a 15-Year-Old Boy with Scleroderma and Secondary Amyloidosis
Pediatrics 103:1475-1479, Hahn,J.S.,et al, 1999

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Control of Primary Angiitis of the CNS Associated with Cerebral Amyloid Angiopathy by Cyclophosphamide Alone
Neurol 52:660-662, Fountain,N.B.&Lopes,B.S., 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Contrast Agent Neurotoxicity Presenting as Subarachnoid Hemorrhage
Neurol 52:1503-1505, Sharp,S.,et al, 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Progression of Mass Effect After Intracerebral Hemorrhage
Stroke 30:1167-1173, Zazulia,A.R.,et al, 1999

Clinicopath Conf,Multifocal Inflammatory Leukoencephalopathy Related to Combination Chemo with Fluorouracil/levamisole
NEJM 341:512-519, Case 24-1999, 1999

Prevalence of Peripheral Neuropathy in Injection Drug Users
Neurol 53:592-597, Berger,A.R.,et al, 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Salvage Chemotherapy with Tamoxifen for Recurrent Anaplastic Astrocytomas
Arch Neurol 56:703-708, Chamberlain,M.C.&Kormanik,P.A., 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

High Incidence of Secondary Brain Tumours after Radiotherapy and Antimetabolites
Lancet 354:34-39, Relling,M.V.,et al, 1999

Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Thrombotic Thrombocytopenic Purpura:Brain CT and MRI Findings in 12 Patients
Neurol 52:1285-1288, Bakshi,R.,et al, 1999

Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Hemorrhage After an Acute Ischemic Stroke
Stroke 30:761-764, Motto,C.,et al, 1999

Parkinsonism after Taking Ecstasy
NEJM 340:1443, Mintzer,S.,et al, 1999

Showing articles 2050 to 2100 of 3506 << Previous Next >>